Sept. 4, 2025 — Ultrasound AI recently announced that the United States Patent and Trademark Office has issued U.S. Patent No. 12,369,883, "Artificial Intelligence System for Determining Clinical Values through Medical Imaging." The patent protects the company's proprietary system for determining current or future clinical or laboratory values directly from non-invasive medical images such as ultrasound.
The company's other significant patents are for Premature Birth Prediction, which permits methods for using ultrasound images to quantitatively predict premature birth and estimate gestational age.
The new grant adds to Ultrasound AI's growing portfolio in obstetrics and broader clinical prediction, and comes on the heels of the company's recently published PAIR (Perinatal Artificial Intelligence in Ultrasound) Study, which reported high accuracy predicting time-to-delivery using only ultrasound images—R² up to 0.95 for term births and 0.92 across all births, based on more than two million images. Together, the study and the patent underscore Ultrasound AI's progress in transforming obstetric care and beyond with scalable, image-only AI.
With today's issuance, Ultrasound AI now holds four U.S. patents and two international patents:
- U.S. 11,266,376 — Premature Birth Prediction (issued March 8, 2022)
- U.S. 11,969,289 — Premature Birth Prediction (issued April 30, 2024)
- U.S. 12,318,249 — Premature Birth Prediction (issued June 3, 2025)
- U.S. 12,369,883 — Artificial Intelligence System for Determining Clinical Values through Medical Imaging (issued July 29, 2025)
- Israel Patent IL298790 — Premature Birth Prediction (issued 2024)
- Singapore Registration No. 11202260793S — Premature Birth Prediction (issued 2024). (Public registry pages are limited; number provided for reference.)
"Securing this latest patent is more than a legal milestone — it further validates our long-term vision that standard ultrasound can unlock powerful, predictive clinical insights in a fast and cost-effective manner at the point of care," said Robert S. Bunn, founder and president of Ultrasound AI. "By protecting methods that determine lab and clinical values from imaging alone, we're paving the way for safer, faster, and more accessible care worldwide."
Ultrasound AI's innovations are already shaping the future of diagnostic imaging, with its Delivery Date AI product serving as the first in a pipeline of AI tools. As the company continues to expand its datasets, partnerships, and regulatory clearances, its patented technologies provide a strong competitive edge in transforming patient care.
To learn more about Ultrasound AI, please visit: https://ultrasound.ai/
December 03, 2025 
